Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

Smoldering multiple myeloma is an asymptomatic, precancerous condition with abnormal plasma cells and elevated monoclonal protein levels. Smoldering multiple myeloma is a complex, intermediary stage ...

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a groundbreaking trial to detect the disease earlier concludes. Scientists working on the ...

Please provide your email address to receive an email when new articles are posted on . Evidence of systemic mast cell activation in the PROSPECTOR study was split into three categories. A REMA score ...

Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this complete guide.

VEXAS syndrome is a rare adult-onset inflammatory disease linked to bone-marrow mutations. Doctors explain why it is often misdiagnosed and why early detection matters.

COLUMBUS, Ga. (WRBL) — The inaugural Operation Ring the Bell 5k is being held on Aug. 9 at Woodruff Park from 6 p.m. to 9 p.m. Alongside the 5k, there will be bone marrow swab testing. All proceeds ...